कोशिश गोल्ड - मुक्त

Dr. Reddy's Misses Q1 Estimates as US Generics Biz Drags

Mint Bangalore

|

July 24, 2025

Dr. Reddy's Laboratories Plans to Launch Weight-Loss Drug Semaglutide in 87 Countries Next Year

- Jessica Jani

Dr. Reddy's Laboratories Ltd.'s US generics business slumped in the June quarter as it faced price erosion in key products like Revlimid used to treat cancer.

US generics revenue declined 11% year-on-year and 4% sequentially to ₹3,412 crore in the first quarter of FY26, according to earnings announced on Wednesday.

The business accounts for 40%, the highest among all segments, of its top line.

The base business remains stable despite the price erosion, the company's management said in a post-earnings press conference.

Mint Bangalore से और कहानियाँ

Mint Bangalore

Mint Bangalore

The vanishing human in customer care

As companies race to automate customer support, speaking to a real person has become a luxury—sometimes even a paid one

time to read

5 mins

November 12, 2025

Mint Bangalore

India's guidelines on AI governance will aid innovation

Last week, the ministry of electronics and information technology released the India AI Governance Guidelines, a proposed framework for governing artificial intelligence (AI).

time to read

3 mins

November 12, 2025

Mint Bangalore

Rupee up 23 paise to 88.50 vs dollar

The rupee appreciated 23 paise to settle at 88.50 against the US dollar on Tuesday, amid progress on the US shutdown bill and optimism over the US-India trade deal.

time to read

1 min

November 12, 2025

Mint Bangalore

Delhi HC bars Patanjali from disparaging competitors

The Delhi High Court has restrained Patanjali Ayurved from telecasting an advertisement which termed other ‘chyawanprash’ products as ‘dhoka’ or ‘deception’ and directed it to take down the advertisement from all electronic, digital and print mediums.

time to read

1 min

November 12, 2025

Mint Bangalore

Mint Bangalore

Red Fort bomb probe finds link to Faridabad module

Module linked to the terror outfit Jaish-e- Mohammad, and a doctor from Pulwama

time to read

3 mins

November 12, 2025

Mint Bangalore

Mint Bangalore

Novo Nordisk lowers Wegovy price

Danish drugmaker Novo Nordisk on Tuesday announced it was slashing the price of its weight-loss drug Wegovy in India. The company said the monthly price of its once-a-week injection would now be 37% cheaper at ₹10,850 for the starting dose from ₹17,345 earlier.

time to read

1 min

November 12, 2025

Mint Bangalore

Mint Bangalore

INDIA’S PUBLIC BANKS: THE 500% MARKET MYSTERY

India’s public sector lenders look poised for another phase of wealth creation

time to read

7 mins

November 12, 2025

Mint Bangalore

Mint Bangalore

China to keep U.S. military from getting its rare-earth magnets

China plans to ease the flow of rare earths and other restricted materials to the U.S. by designing a system that will exclude companies with ties to the U.S. military while fast-tracking export approvals for other firms, according to people familiar with the plan.

time to read

2 mins

November 12, 2025

Mint Bangalore

Berry’s quick exit puts Britannia investors in a tough spot

Shares of Britannia Industries Ltd closed 3% lower on Tuesday after the board accepted Varun Berry’s resignation and relieved him from his position as vice-chairman, managing director (MD) and chief executive officer (CEO) on 10 November. Rakshit Hargave will take over as MD and CEO from 15 December.

time to read

1 mins

November 12, 2025

Mint Bangalore

Mint Bangalore

AI helps us leapfrog, change lives: Google India’s Lobana

Co bets on local capacity, data centres, partnerships with Indian startups, governments

time to read

3 mins

November 12, 2025

Listen

Translate

Share

-
+

Change font size